We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleProinsulin peptide immunotherapy in type 1 diabetes: report of a first-in-man Phase I safety study.AuthorsThrower SL; James L; Hall W; Green KM; Arif S; Allen JS; Van-Krinks C; Lozanoska-Ochser B; Marquesini L; Brown S; Wong FS; Dayan CM; Peakman MPublicationClinical and experimental immunology, 2009, Vol 155, Issue 2, p156ISSN1365-2249Publication typearticleDOI10.1111/j.1365-2249.2008.03814.x